Payers and the ABCs of digital literacy

With the growing adoption of new digital technologies to improve patient care, comes the need to demonstrate their benefits to all stakeholders, including payers. Showing that patients and HCPs understand, can use and benefit from digital elements is an important but arguably under addressed aspect of securing reimbursement for them. By putting patients at the heart of everything the company does, they are more likely to feel engaged and inspired to embrace new technologies, give themselves an injection or use an app, even if they are not digitally savvy.“Patients that are informed and engaged are more adherent to their medicines,” says Lori Hall, director of global health literacy at Eli Lilly and Company. “And greater adherence leads to better outcomes. This is a universal goal for payers, HCPs, patients and pharma alike.”Not taking the time to test that the supplemental information around digital health apps is easy to understand and easy to use by the intended patients, on the other hand, will mean new digital health technologies have little chance of success, says Hall.“All too often the industry assumes patients understand the information we provide about what is required of a new medicine or a digital add-on. Yet the readability of those documents often test far above the health literacy skills of the average patient. This communication gap is an under-address ed area that is hiding in plain sight.” Testing assumptions Hall cites an early pilot Lilly did to...
Source: EyeForPharma - Category: Pharmaceuticals Authors: Source Type: news